Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-08-03Clinical Trial Update: Interactions of Fronto-Parietal High Frequency rTMS on Anterior Cingulate Cortex Activation in Schizophrenia [NA]
A completed clinical trial study investigates how high-frequency rTMS over fronto-parietal areas affects anterior cingulate cortex activatio…
-
CLINICAL_TRIALS trial_result · 2023-07-28Clinical Trial Update: rTMS as a Probe of Episodic Memory Neurocircuitry in Schizophrenia [NA]
Completed clinical trial investigating rTMS as a probe of episodic memory neurocircuitry in schizophrenia with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-07-28Clinical Trial Update: Safety, Tolerability, Pharmacokinetics and Efficacy Study of HS-10380 in Patients With Schizophrenia [Phase 1, Phase 2]
Phase 1/Phase 2 clinical trial update for HS-10380 in schizophrenia focusing on safety, tolerability, pharmacokinetics, and efficacy.
-
CLINICAL_TRIALS trial_result · 2023-07-21Clinical Trial Update: Siltuximab in Schizophrenia [Phase 1, Phase 2]
Clinical trial update for siltuximab in schizophrenia exploring Phase 1 and Phase 2 data.
-
CLINICAL_TRIALS trial_result · 2023-07-20Clinical Trial Update: Add-on Aripiprazole on Cardiometabolic Profile in Treatment Resistant Schizophrenia: RCT [Phase 4]
Phase 4 clinical trial evaluating add-on aripiprazole and its effect on cardiometabolic risk in treatment-resistant schizophrenia.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-07-17Clinical Trial Update: Relapse Prevention Study in Patients With Schizophrenia [Phase 3]
Phase 3 relapse prevention study in schizophrenia has completed; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-06-18Clinical Trial Update: Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia [Phase 3]
Phase 3 trial assessing dexmedetomidine for agitation in schizophrenia completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-06-18Clinical Trial Update: Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia [Phase 3]
Phase 3 clinical trial evaluating dexmedetomidine for agitation in schizophrenia completed with posted results.
-
CLINICAL_TRIALS trial_result · 2023-06-15Clinical Trial Update: Trial to Investigate the Safety and Efficacy of GWP42003-P Versus Placebo as Adjunctive Therapy in Participants With Schizophrenia Experiencing Inadequate Response to Ongoing Antipsychotic Treatment [Phase 2]
Phase 2 trial investigating GWP42003-P as adjunctive therapy in schizophrenia with inadequate response to antipsychotics; study terminated w…
-
CLINICAL_TRIALS trial_result · 2023-06-15Clinical Trial Update: Prebiotic Treatment in People With Schizophrenia - Pilot Study [Phase 4]
Phase 4 pilot trial evaluating prebiotic treatment in people with schizophrenia and schizoaffective disorder; completed with results posted …
-
CLINICAL_TRIALS trial_result · 2023-05-31Clinical Trial Update: A Study of Paliperidone Palmitate 6-Month Formulation [Phase 3]
Phase 3 study evaluating paliperidone palmitate for schizophrenia has completed and posted results for the 6-month formulation.
-
CLINICAL_TRIALS trial_result · 2023-05-25Clinical Trial Update: Models of Auditory Hallucination [NA]
A clinical trial studying models of auditory hallucination in individuals with schizophrenia or schizoaffective disorder was terminated, and…
-
CLINICAL_TRIALS trial_result · 2023-05-15Clinical Trial Update: Treatment of Cognitive and Negative Symptoms in Schizophrenia With N-acetylcysteine [Phase 4]
Phase 4 trial update evaluating N-acetylcysteine for cognitive and negative symptoms in schizophrenia has completed recruitment.
-
CLINICAL_TRIALS trial_result · 2023-04-28Clinical Trial Update: Study to Evaluate Efficacy and Safety of Roluperidone (MIN-101) in Adult Patients With Negative Symptoms of Schizophrenia [Phase 3]
Phase 3 clinical trial evaluating Roluperidone (MIN-101) for negative symptoms of schizophrenia has completed and results were posted in 202…
-
CLINICAL_TRIALS trial_result · 2023-04-26Clinical Trial Update: A 6-month Study to Evaluate Sulforaphane Effects in Schizophrenia Patients [Phase 2]
A Phase 2 clinical trial evaluating sulforaphane in schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2023-04-21Clinical Trial Update: Feasibility Electrical Stimulation Study for Visual Hallucinations [NA]
A completed feasibility study evaluating electrical stimulation for visual hallucinations in schizophrenia, schizoaffective disorder, and bi…
-
CLINICAL_TRIALS trial_result · 2023-04-03Clinical Trial Update: A Study Measuring Effect of LY2140023 (Pomaglumetad Methionil) on Electrocardiographs in Participants With Schizophrenia [Phase 1]
Phase 1 trial update examining the effect of LY2140023 (pomaglumetad methionil) on ECGs in participants with schizophrenia; study completed …
-
CLINICAL_TRIALS trial_result · 2023-03-23Clinical Trial Update: Skills Training to Enhance Vocational Outcomes in Veterans With Serious Mental Illness [NA]
Completed clinical trial evaluating skills training to improve vocational outcomes in veterans with serious mental illness; results posted i…
-
CLINICAL_TRIALS trial_result · 2023-03-13Clinical Trial Update: tDCS and Cognitive Training Intervention for Chronic Smokers With Schizophrenia [NA]
Clinical trial on transcranial direct current stimulation plus cognitive training for chronic smokers with schizophrenia; status TERMINATED …
-
CLINICAL_TRIALS trial_result · 2023-02-27Clinical Trial Update: Translational Neuroscience Optimization of GlyT1 Inhibitor [Phase 2]
Phase 2 clinical trial evaluating a glycine transporter 1 (GlyT1) inhibitor for cognitive impairment in schizophrenia has completed, with re…
-
CLINICAL_TRIALS trial_result · 2023-02-08Clinical Trial Update: A 6-week Study to Evaluate the Efficacy and Safety of Lurasidone HCL in Acutely Psychotic Patients With Schizophrenia [Phase 3]
A Phase 3 clinical trial evaluating the efficacy and safety of lurasidone HCl in acutely psychotic patients with schizophrenia has completed…
-
CLINICAL_TRIALS trial_result · 2023-02-08Clinical Trial Update: A Multiple Dose Study to Assess the Safety, Tolerability and PK of Risperidone Extended Release Capsules [Phase 2]
A Phase 2 multiple-dose study evaluated safety, tolerability, and pharmacokinetics of risperidone extended-release capsules in schizophrenia…
-
CLINICAL_TRIALS trial_result · 2023-02-06Clinical Trial Update: Acetylcholine, Tobacco Smoking, Genes and Nicotinic Receptors [NA]
Clinical trial update related to acetylcholine, tobacco smoking, genes, and nicotinic receptors; completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-01-31Clinical Trial Update: Biomarker and Safety Study of Clozapine in Patients With Benign Ethnic Neutropenia (BEN) [NA]
Clinical trial update on biomarker and safety study of clozapine in patients with benign ethnic neutropenia (BEN) completed; results posted.
-
CLINICAL_TRIALS trial_result · 2023-01-26Clinical Trial Update: A Study of Cognitive Adaptation Training in Inpatient Forensic Environments
A completed clinical trial evaluating Cognitive Adaptation Training in inpatient forensic settings for schizophrenia.